Remicade (Infliximab) (Rheumatoid Arthritis) Market Analysis and Segment Forecasts to 2023

Submitted by: Submitted by

Views: 10

Words: 843

Pages: 4

Category: Business and Industry

Date Submitted: 03/28/2016 01:53 AM

Report This Essay

Remicade (infliximab) (Rheumatoid Arthritis) Market Size, Share, Trends,

Company Profiles, Demand, Insights, Analysis, Research, Report,

Opportunities, Segmentation and Forecast To 2023

Summary

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and

deformity of the joints. It affects over seven million individuals in the 10MM covered in this

report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the

prevalence is expected to grow to just over 8.5 million individuals by 2023. The anti-TNFs have

been effective in treating the signs and symptoms of RA and inhibiting progression to erosive

bone disease. However, the landscape is quickly changing with the introduction of biosimilars,

novel biologics, and a class of oral therapies known as JAK inhibitors, all of which will change

the market dynamics between 2013 and 2023. With the anti-TNFs as extremely effective

therapies for RA, the market is extremely competitive for new entrants and will undergo further

pressure as biosimilars are approved and launch.

Remicade (infliximab) was originally developed as a result of a collaboration between two

professors at NYU Langone Medical Center and Centocor Ortho Biotech (acquired by Janssen

Biotech, a subsidiary of J&J) (NYU Langone Medical Center, press release, August 12, 2005). It

is first-generation TNF inhibitor consisting of a chimeric IgG1 mAb that is specific for TNFa.

Remicade binds to TNFa with high affinity, neutralizing the effects of this cytokine, thus

preventing synovial inflammation and decreasing joint erosion in patients with RA.

Read Complete Report with TOC: http://www.radiantinsights.com/research/remicadeinfliximab-rheumatoid-arthritis-forecast-and-market-analysis-to-2023

Scope

- Overview of Rheumatoid Arthritis, including epidemiology, etiology, symptoms, diagnosis,

pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed...